Foresite Capital Management V
Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001792206
Tip: Access up to 7 years of quarterly data
Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Foresite Capital Management V
Companies in the Foresite Capital Management V portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Kinnate Biopharma (KNTE) | 25.8 | $35M | 875k | 39.78 | ||
| Alx Oncology Hldgs (ALXO) | 20.4 | $28M | 320k | 86.20 | ||
| Relay Therapeutics (RLAY) | 12.3 | $17M | 400k | 41.56 | ||
| Nurix Therapeutics (NRIX) | 11.0 | $15M | 452k | 32.88 | ||
| Oaktree Acquisition Corp. Shs Cl A | 9.4 | $13M | 871k | 14.60 | ||
| Population Health Investment Unit (PHICU) | 7.4 | $10M | 960k | 10.45 | ||
| Therapeutics Acquisition Corp Com Cl A (RACA) | 3.6 | $4.9M | 350k | 13.92 | ||
| Bctg Acquisition Corp (BCTG) | 3.4 | $4.6M | 400k | 11.44 | ||
| Lifesci Acquisition Ii Corp (LSAQ) | 3.2 | $4.3M | 400k | 10.67 | ||
| Helix Acquisition Corp. Com Cl A (HLXA) | 2.1 | $2.8M | 250k | 11.37 | ||
| Consonance-HFW Acquisition Corp. Unit | 0.8 | $1.0M | 100k | 10.47 | ||
| Abcellera Biologics (ABCL) | 0.6 | $805k | 20k | 40.25 |
Past Filings by Foresite Capital Management V
SEC 13F filings are viewable for Foresite Capital Management V going back to 2020
- Foresite Capital Management V 2020 Q4 filed Feb. 16, 2021